We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $168M
1-Year Est. Return 60.36%
This Fund
S&P 500
This Quarter Est. Return
+3.86%
1 Year Est. Return
+60.36%
3 Year Est. Return
+143.93%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$238M
AUM Growth
-$511K
Cap. Flow
-$4.31M
Cap. Flow %
-1.81%
Top 10 Hldgs %
56.07%
Holding
204
New
16
Increased
9
Reduced
10
Closed
19

Top Buys

Rank Stock Value
1
CDXS icon
Codexis
CDXS
+$1.79M
2
GSK icon
GSK
GSK
+$1.52M
3
FIP icon
FTAI Infrastructure
FIP
+$1.21M
4
FSTX
F-star Therapeutics, Inc. Common Stock
FSTX
+$1.01M
5
AVDL
Avadel Pharmaceuticals
AVDL
+$920K

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$3.65M
2
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
+$3.07M
3
INCY icon
Incyte
INCY
+$2.04M
4
INVA icon
Innoviva
INVA
+$1.7M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.48M

Sector Composition

Rank Sector Weight
1 Healthcare 32.49%
2 Materials 25.45%
3 Financials 10.86%
4 Real Estate 6.17%
5 Communication Services 4.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EWU icon
176
iShares MSCI United Kingdom ETF
EWU
$4.09B
$3K ﹤0.01%
116
– –
OXY.WS icon
177
Occidental Petroleum Corp Warrants
OXY.WS
$31.4B
$3K ﹤0.01%
+158
New +$6.66K
EFV icon
178
iShares MSCI EAFE Value ETF
EFV
$28.3B
$2K ﹤0.01%
63
– –
EZU icon
179
iShare MSCI Eurozone ETF
EZU
$9.4B
$2K ﹤0.01%
55
– –
SCU
180
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$2K ﹤0.01%
200
– –
WAB icon
181
Wabtec
WAB
$51B
$1K ﹤0.01%
12
– –
INVA icon
182
Innoviva
INVA
$1.59B
– –
-115,269
Closed -$1.7M
IVV icon
183
iShares Core S&P 500 ETF
IVV
$868B
– –
-429
Closed -$163K
REGN icon
184
Regeneron Pharmaceuticals
REGN
$72.2B
– –
-2,500
Closed -$1.48M
RPV icon
185
Invesco S&P 500 Pure Value ETF
RPV
$1.67B
– –
-78
Closed -$6K
RSP icon
186
Invesco S&P 500 Equal Weight ETF
RSP
$98B
– –
-96
Closed -$13K
SVC
187
Service Properties Trust
SVC
$1.05B
– –
-200
Closed -$5K
T icon
188
AT&T
T
$172B
– –
-20,000
Closed -$419K
VNQ icon
189
Vanguard Real Estate ETF
VNQ
$40.2B
– –
-74
Closed -$7K
XBI icon
190
State Street SPDR S&P Biotech ETF
XBI
$10.1B
– –
-800
Closed -$59K
FAZE
191
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
– –
-2,000
Closed -$20K
WARR.WS
192
DELISTED
Warrior Technologies Acquisition Company Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
WARR.WS
– –
-12,500
Closed -$144K
WARR
193
DELISTED
Warrior Technologies Acquisition Company
WARR
– –
-25,000
Closed -$249K
RDUS
194
DELISTED
Radius Health, Inc.
RDUS
– –
-97,888
Closed -$1.01M
MIC
195
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
– –
-10,350
Closed -$40K
ETTX
196
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
– –
-41,700
Closed -$92K
SRRA
197
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
– –
-55,758
Closed -$3.07M
BHVN
198
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-25,051
Closed -$3.65M
4 5 6 7
8

Similar funds

DI
Disciplined Investors Waco, Texas $168M AUM 23.6% 1-Year Est. Return
WFS
Widmann Financial Services Bowie, Maryland $168M AUM 24.36% 1-Year Est. Return
CCG
Catalina Capital Group Torrance, California $168M AUM 16.69% 1-Year Est. Return
7CM
7G Capital Management New York $168M AUM 45.68% 1-Year Est. Return
MAG
Meadowbrook Advisors Group Bedminster, New Jersey $168M AUM
PFA
Presper Financial Architects Akron, Ohio $168M AUM 12.94% 1-Year Est. Return
CW
Code Waechter Tampa, Florida $168M AUM 15.56% 1-Year Est. Return
IWA
Integrity Wealth Advisors Ventura, California $168M AUM 18.33% 1-Year Est. Return

David M. Knott Jr's Q3 2022 Portfolio in Review

As of Q3 2022, David M. Knott Jr held 204 positions worth $238M, down 0.21% from $238M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

David M. Knott Jr's Q3 2022 filing shows 16 new, 9 increased, 10 reduced and 19 closed positions. Its largest new stake was Codexis: 222,107 shares worth $1.35M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $3.65M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 34% a quarter earlier, followed by Materials and Financials.

  • David M. Knott Jr's largest Q3 2022 buy was Codexis: 222,107 shares worth $1.35M.
  • David M. Knott Jr added most to F-star Therapeutics, Inc. Common Stock in Q3 2022, an estimated $1.01M increase.
  • David M. Knott Jr's biggest Q3 2022 reduction was Incyte, cutting an estimated $2.04M.
  • David M. Knott Jr fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $3.65M.
  • David M. Knott Jr's ten largest holdings make up 56% of its $238M portfolio in Q3 2022.
  • David M. Knott Jr opened 16 new positions and closed 19 in Q3 2022.
  • David M. Knott Jr's portfolio value fell 0.21% quarter-over-quarter to $238M.

Based on David M. Knott Jr's 13F filing for Q3 2022, filed 10 Nov 2022.